Visitor restrictions and mask requirements are still in place at all Scripps facilities. If you suspect you have COVID, please visit MyScripps first and answer the COVID-19 Symptom Checker questions. 

Your browser is out-of-date!

Internet Explorer 11 has been retired by Microsoft as of June 15, 2022. To get the best experience on this website, we recommend using a modern browser, such as Safari, Chrome or Edge.


Cordella Investigational device for Heart Failure patients

Trial ID:
Thomas Heywood, M.D.
This is a clinical trial to evaluate the safety and effectiveness of the Cordella PA Sensor System in patients with New York Heart Association Class III Heart Failure.

Inclusion Criteria

Patients must:
  • Be at least 18 years of age
  • Have been diagnosed with NYHA III heart failure and treated for more than 3 months
  • Be on stable, optimally titrated medical therapy for at least 30 days
  • Have had a heart failure hospitalization within 12 months

Exclusion Criteria

Patients must not:
  • Have a history of recurrent pulmonary embolism
  • Have unrepaired severe valvular disease
  • Have a history of life threatening allergy to contrast dye

Additional Info

  • Study participants will receive the investigational Cordella PA Sensor System Implant. All treatments and physician visits will take place at Anderson Medical Pavilion. Follow-up visits will occur at 1, 3, 6, 12, 18, and 24 months and year 3 after the implant procedure.
  • Search NCT # 04089059 @ website

Contact Info:

  • Clinical Research Leadership